• HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Thursday, March 4, 2021
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Christof Niehrs of IMB elected as a member of the American Academy of Arts and Sciences

Bioengineer by Bioengineer
April 28, 2016
in Cancer
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

The Academy convenes leaders from the academic, business, and government sectors to address key challenges faced by today's global society. Through studies, publications, and programmes on various areas of the Arts and Sciences, the Academy provides authoritative and nonpartisan policy advice to decision-makers in government, academia, and the private sector. It currently has 4,600 Fellows and 600 Foreign Honorary Members. These include many of the most accomplished scholars and practitioners worldwide. Notable past Foreign Honorary Members of the society include Alexander von Humboldt, Charles Darwin, and Werner Heisenberg.

"I am honoured to have been elected to join such an exceptional group of scholars", says Christof Niehrs, "and I am very much looking forward to participating in the Academy's activities." Professor Niehrs is the Founding and Scientific Director of the Institute of Molecular Biology (IMB), which opened on the campus of Johannes Gutenberg University Mainz (JGU), Germany, in 2011. He is a developmental biologist who has received a number of honours and awards for his pioneering research into mechanisms underlying early embryonic development. His current research focusses on two fields, epigenetics of DNA methylation and Wnt growth factor signalling, both aiming to unravel how cells regulate differentiation and avoid disease.

Christof Niehrs is among 213 respected artists and scientists who have been elected to membership of the American Academy this year and one of the 37 Foreign Honorary Members. Other members of the 2016 class include winners of the Pulitzer Prize and the Wolf Prize, MacArthur and Guggenheim Fellowships, the Fields Medal as well as the Grammy and National Book Awards.

"It is an honour to welcome this new class of exceptional women and men as part of our distinguished membership," said Don Randel, Chair of the Academy's Board of Directors, in a press release. "Their election affords us an invaluable opportunity to bring their expertise and knowledge to bear on some of the most significant challenges of our day. We look forward to engaging these new members in the work of the Academy."

The new members of the Academy will be inducted at a ceremony on Oct. 08, 2016 at its headquarters in Cambridge, Massachusetts, USA.

###

Further information about Christof Niehrs' research can be found at http://www.imb.de/niehrs.

About the Institute of Molecular Biology gGmbH

The Institute of Molecular Biology gGmbH (IMB) is a centre of excellence in the life sciences that was established in 2011 on the campus of Johannes Gutenberg University Mainz (JGU). Research at IMB concentrates on three cutting-edge areas: epigenetics, developmental biology, and genome stability. The institute is a prime example of a successful collaboration between public authorities and a private foundation. The Boehringer Ingelheim Foundation has dedicated 100 million euros for a period of ten years to cover the operating costs for research at IMB, while the state of Rhineland-Palatinate provided approximately 50 million euros for the construction of a state-of-the-art building. For more information about IMB, please visit http://www.imb.de.

About the Boehringer Ingelheim Foundation

The Boehringer Ingelheim Foundation is an independent, non-profit organisation committed to the promotion of the medical, biological, chemical and pharmaceutical sciences. It was established in 1977 by Hubertus Liebrecht (1931-1991), a member of the shareholder family of the company Boehringer Ingelheim. With the PLUS 3 Perspectives Programme and the Exploration Grants, the foundation supports independent group leaders. It also endows the internationally renowned Heinrich Wieland Prize as well as awards for up-and-coming scientists. In addition, the foundation pledged to donate 100 million euros to finance the scientific running of the IMB at Johannes Gutenberg University Mainz for ten years. In 2013, the Boehringer Ingelheim Foundation donated a further 50 million euros to Johannes Gutenberg University Mainz. http://www.boehringer-ingelheim-stiftung.de.

Media Contact

Dr. Ralf Dahm
[email protected]
49-613-139-21455
@uni_mainz_eng

http://www.uni-mainz.de

The post Christof Niehrs of IMB elected as a member of the American Academy of Arts and Sciences appeared first on Scienmag.

Share12Tweet7Share2ShareShareShare1

Related Posts

IMAGE

Engineered safety switch curbs severe side effects of CAR-T immunotherapy

March 4, 2021
IMAGE

HKBU develops dual-targeting drug for EBV-related cancers

March 2, 2021

2nd window ICG predicts gross-total resection/progression-free survival in brain metastasis

March 2, 2021

Future of immunotherapy could be ‘off-the-shelf’ treatments

March 1, 2021

Leave a Reply Cancel reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

POPULAR NEWS

  • IMAGE

    Terahertz accelerates beyond 5G towards 6G

    667 shares
    Share 267 Tweet 167
  • People living with HIV face premature heart disease and barriers to care

    84 shares
    Share 34 Tweet 21
  • Global analysis suggests COVID-19 is seasonal

    38 shares
    Share 15 Tweet 10
  • HIV: an innovative therapeutic breakthrough to optimize the immune system

    36 shares
    Share 14 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Tags

Medicine/HealthTechnology/Engineering/Computer ScienceClimate ChangecancerChemistry/Physics/Materials SciencesCell BiologyBiologyGeneticsPublic HealthEcology/EnvironmentInfectious/Emerging DiseasesMaterials

Recent Posts

  • From perceptrons to deep learning
  • Collagen plays protective role during pancreatic cancer development
  • Zinc oxide: key component for the methanol synthesis reaction over copper catalysts
  • Determination of glycine transporter opens new avenues in development of psychiatric drugs
  • Contact Us

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In